CNBC Daily Open: Under Trump, business and politics are becoming bedfellows

The Trump administration is reportedly considering acquiring a stake in Intel, a move primarily driven by the chipmaker's unique position as the only U.S.-born company capable of manufacturing advanced semiconductors domestically. This consideration is part of a broader strategy to consolidate a U.S. chip supply chain, which also includes revenue sharing agreements with Nvidia and AMD for China sales, and Apple's commitment to increased domestic chip production. Intel's shares surged 7.4% following the Bloomberg report, reflecting investor reaction to the potential government backing and strategic implications for U.S. technological independence.

Analysis

The potential for the U.S. government to take a stake in Intel Corp. marks a significant potential shift in industrial policy, driven by national security and supply chain sovereignty concerns. This consideration, stemming from Intel's unique position as the only U.S.-domiciled firm capable of manufacturing the most advanced semiconductors domestically, triggered a 7.4% surge in its stock price, reflecting strong investor optimism about a government backstop. The move appears to be part of a broader, concerted effort by the administration to consolidate a U.S.-centric chip ecosystem. This strategy is further evidenced by new agreements where Nvidia and AMD will pay the U.S. government a 15% share of their revenue from chip sales in China, effectively a tax that underscores the geopolitical risks for firms with heavy China exposure. In contrast, Apple's commitment to increase domestic chip production aligns with this strategic goal. While U.S. markets remain near highs, the faltering economic data from China in July—with retail sales, industrial output, and fixed-asset investment all underperforming—presents a notable headwind for global technology demand. Separately, Berkshire Hathaway's new $1.6 billion investment in UnitedHealth provides a strong vote of confidence in the healthcare sector, offering a diversification signal away from the increasingly politicized tech industry.

Key Decisions for Investors

• Investors should view the potential U.S. government stake in Intel not just as a financial backstop but as a significant strategic de-risking, positioning the company as a critical asset in U.S. technology policy.
• Holders of Nvidia and AMD must immediately model the margin impact of the 15% revenue share on China sales, as this introduces a material geopolitical cost and a direct headwind to profitability.
• It is now critical to re-evaluate semiconductor portfolios based on geopolitical alignment, as U.S. policy is actively creating distinct winners, such as domestically-focused manufacturers like Intel, while penalizing firms with heavy operational or sales exposure to China.
• The new $1.6 billion stake by Berkshire Hathaway provides a strong vote of confidence in UnitedHealth's fundamentals, suggesting investors could re-examine the healthcare firm's long-term value proposition as a potential haven from tech sector volatility.